Navigation Links
Cumberland Pharmaceuticals Reports Second Quarter 2010 Financial Results
Date:8/16/2010

f Caldolor in Australia. If approved, Phebra will handle all ongoing regulatory requirements, product marketing, distribution and sales in the territory. Cumberland maintains responsibility for product formulation, development and manufacturing, and receives upfront and milestone payments as well as royalties on future sales in exchange for the product license.

Field Sales Force Conversion

In July 2010, Cumberland began the process of converting its field sales force, which promotes Kristalose and Caldolor, from contract representatives with Ventiv Health to Cumberland employees. The contractual relationship with Ventiv provided Cumberland with a right to convert the sales force to Cumberland employees at its discretion. In 2007, Cumberland converted its hospital sales force from its contractual status in the same manner. The Company expects to complete the field sales force conversion in September 2010 and is pleased to welcome these individuals as Cumberland employees.

SUPPLEMENTAL FINANCIAL INFORMATIONThe following table presents a reconciliation of Cumberland's net income to EBITDA and adjusted EBITDA. The Company defines EBITDA as net income plus interest, income tax, depreciation and amortization, and presents these measures to assist investors in evaluating Cumberland's operating performance and comparing the Company's results with those of other companies. EBITDA and adjusted EBITDA should not be considered in isolation from or as a substitute for net income.Three Months Ended June 30,20102009Net income $
279,777 $
287,415 Income tax expense374,461 232,637 Depreciation & amortization232,344 202,282 Interest (income) expense, net355,622 74,064 EBITDA,242,204 796,398 Adjustments:   Non-cash stock compensation204,343 ,164,383 Adjusted EBITDA $
,446,547 $
,960,781 Six Months Ended June 30,20102009Net income $
593,275 $
,493,266 Income tax expense586,198 ,063,696 Depreciation & amortization463,676 3
'/>"/>

SOURCE Cumberland Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Cumberland Pharmaceuticals to Present at the Wells Fargo Healthcare Conference in Boston on June 23, 2010
2. Cumberland Pharmaceuticals to Present at Jefferies Global Life Sciences Conference in New York on June 8, 2010
3. Cumberland Pharmaceuticals To Announce First Quarter 2010 Financial Results on May 13, 2010
4. Cumberland Pharmaceuticals Partners in Canada With Alveda Pharmaceuticals to Commercialize Caldolor(R)
5. Cumberland Pharmaceuticals Reports 24% Increase in Net Revenue With Full Year 2009 Financial Results
6. Cumberland Pharmaceuticals Donates Caldolor(R) to Haitian Relief Effort
7. Cumberland Pharmaceuticals and Phebra Pty Ltd. Sign Exclusive Agreement for Commercialization of Caldolor(R) in Australia and New Zealand
8. Cumberland Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 10, 2009
9. Ferring Pharmaceuticals FIRMAGON® Joins Race to End Prostate Cancer as Official Sponsor of the Great Prostate Cancer Challenge / Dash for Dad
10. Jiangbo Pharmaceuticals Announces the Commercial Launch of Felodipine Sustained Release Tablets
11. Lotus Pharmaceuticals Reports Strong Second Quarter 2010 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... SEATTLE und TÜBINGEN, Deutschland, 5. ... Melinda Gates Stiftung und das deutsche biopharmazeutische ... Stiftung 46 Millionen Euro (52 Millionen US-Dollar) ... im Bereich der medizinisch angewandten Messenger-RNA (mRNA). ... neue Ansätze zur Behandlung von Krankheiten und ...
(Date:3/5/2015)...  BioPhotas, Inc., an FDA registered medical device manufacturer ... to treat skin, muscle and joint conditions, today announced ... to provide BioPhotas, flagship product, the Celluma, ... Commenting on the alliance, Patrick ... Celluma at the Warrior Hope and Care Center had ...
(Date:3/5/2015)... 5, 2015  Sanomedics, Inc. (OTC: SIMH, SIMHD) ("Sanomedics" ... on developing, manufacturing, and acquiring cutting-edge technology, products and ... will be exhibiting at booth # 709 at the ... (NAPNAP) taking place on March 11-13, 2015 at Caesars ... The 36 th annual NAPNAP ...
Breaking Medicine Technology:Bill & Melinda Gates Stiftung investiert in CureVac zur Entwicklung innovativer Impfstoffe 2Bill & Melinda Gates Stiftung investiert in CureVac zur Entwicklung innovativer Impfstoffe 3Bill & Melinda Gates Stiftung investiert in CureVac zur Entwicklung innovativer Impfstoffe 4BioPhotas, Inc. and the Semper Fi Fund Work Together to Provide Pain Relief to Injured Service Members 2BioPhotas, Inc. and the Semper Fi Fund Work Together to Provide Pain Relief to Injured Service Members 3Sanomedics to Showcase the Caregiver at National Association of Pediatric Nurse Practitioners Conference 2Sanomedics to Showcase the Caregiver at National Association of Pediatric Nurse Practitioners Conference 3
... ABBOTT PARK, Ill., March 11 The ... review the supplemental new drug application (sNDA) of a ... Depot (leuprolide acetate for depot ... prostate cancer.  Palliative treatment helps to relieve symptoms associated ...
... HARBIN, China , March 11 /PRNewswire-Asia-FirstCall/ -- ... a,developer, manufacturer and distributor of botanical products,bio-pharmaceuticals and traditional ... its Shengmai Granules price by 12%. Shengmai,Granule is an ... ...
Cached Medicine Technology:Abbott Seeks FDA Approval of a New Six-Month 45-mg Formulation of Lupron(R) Depot for the Palliative Treatment of Advanced Prostate Cancer 2Abbott Seeks FDA Approval of a New Six-Month 45-mg Formulation of Lupron(R) Depot for the Palliative Treatment of Advanced Prostate Cancer 3Abbott Seeks FDA Approval of a New Six-Month 45-mg Formulation of Lupron(R) Depot for the Palliative Treatment of Advanced Prostate Cancer 4Abbott Seeks FDA Approval of a New Six-Month 45-mg Formulation of Lupron(R) Depot for the Palliative Treatment of Advanced Prostate Cancer 5Abbott Seeks FDA Approval of a New Six-Month 45-mg Formulation of Lupron(R) Depot for the Palliative Treatment of Advanced Prostate Cancer 6Abbott Seeks FDA Approval of a New Six-Month 45-mg Formulation of Lupron(R) Depot for the Palliative Treatment of Advanced Prostate Cancer 7Renhuang Announces Price Increase on Shengmai Granules 2Renhuang Announces Price Increase on Shengmai Granules 3Renhuang Announces Price Increase on Shengmai Granules 4
(Date:3/5/2015)... 2015 Califia Farms , the ... natural products coffee drinks category[1], today unveils its new ... in Anaheim, Calif. Concentrated Cold Brew (CCB) is ... which democratizes the next wave of the coffee-taste evolution ... to become their own baristas. , Califia Farms ...
(Date:3/5/2015)... 05, 2015 For PASCHA Chocolate, less ... essential ingredients, the robust flavor of the cacao bean ... PASCHA Chocolate is free from peanuts, nuts, dairy, soy, ... offering March 6th- 8th at Expo West., ... Chocolate has broken new ground with their New PASCHA ...
(Date:3/5/2015)... March 05, 2015 Leading nutritional supplement ... week’s Arnold Sports Festival and Arnold Fitness EXPO ... Metabolic Nutrition will host a display booth featuring free ... E.S.P. and its highly-popular, class-leading fat burner Synedrex. The ... unique recipes that utilize its top-of-the-line supplements and miniature ...
(Date:3/5/2015)... March 05, 2015 Jordan Valley Medical ... as a treatment option for sudden cardiac arrest. When ... rhythm and can detect any life-threatening abnormalities. If an ... the patient before delivering a treatment shock to restore ... Elhaddi of Jordan Valley Medical Center and the Heart ...
(Date:3/5/2015)... IL (PRWEB) March 05, 2015 The ... announce their sponsorship of the upcoming Crain’s Chicago Business ... , The Physicians' Breakfast will take place from 7:30 ... East Pearson Street, Chicago, IL 60611. The morning’s events ... Chicago’s top healthcare professionals. , The panel discussion ...
Breaking Medicine News(10 mins):Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 2Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 3Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 4Health News:PASCHA Allergen Free Organic Chocolate to Appear at Natural Products Expo West March 6-8, 2015 2Health News:Metabolic Nutrition Exhibiting at 2015 Arnold Sports Festival and Fitness EXPO This Week 2Health News:New Technology Behind LifeVest® Wearable Defibrillator Saves the Life of Utah Man in Cardiac Arrest 2Health News:New Technology Behind LifeVest® Wearable Defibrillator Saves the Life of Utah Man in Cardiac Arrest 3Health News:Cook County Law Firm to Sponsor Physicians Breakfast 2
... Nashville ... Dental Association (NDA) at 6 p.m. on December 5 at the Loews Vanderbilt Plaza Hotel ... Nashville, Tenn. ... the 86th president of the National Dental Association (NDA) at 6 p.m. on December 5 ...
... ... N.Y. Times #1 best-seller KNOCKOUT , ... Cornwall, NY (PRWEB) December 2, 2009 -- In her new book KNOCKOUT, Interviews ... Place, Suzanne Somers interviews doctors who are successfully using the most innovative cancer treatments--treatments that ...
... ... released his first full-length book, Short White Coat: Lessons from Patients on Becoming a Doctor, ... , ... December 2, 2009 -- Most people will, at some point or another, either find themselves ...
... , CAMPBELL, Calif., Dec. ... Dr. Rafael Pelayo, Associate Professor at the Stanford Sleep Disorders Clinic ... Sound Machine as part of a healthy sleep plan for people ... drugs. , "Background noise is a problem for people when they ...
... CHICAGO, Dec. 2 A randomized, controlled study comparing standard ... decompression for painful herniated disc revealed that while both treatments ... patients pain free up to two years later. Results of ... at the annual meeting of the Radiological Society of North ...
... , SEATTLE, Dec. 2 ... that Ruth Pettengell, M.D. of St. George,s Hospital, University of ... will present new data on the pixantrone phase III trial ... Meeting of the American Society of Hematology on Saturday, December ...
Cached Medicine News:Health News:Meharry Medical College Officer Will Head the National Dental Association 2Health News:Meharry Medical College Officer Will Head the National Dental Association 3Health News:Innovative Biofeedback Technology Wins By A "Knockout." 2Health News:Innovative Biofeedback Technology Wins By A "Knockout." 3Health News:Innovative Biofeedback Technology Wins By A "Knockout." 4Health News:Beneath the Short White Coat: A Medical Student Reveals All 2Health News:Sleep Specialist Dr. Rafael Pelayo Recommends ASTI's Ecotones Duet Sleep Sound Machine 2Health News:Sleep Specialist Dr. Rafael Pelayo Recommends ASTI's Ecotones Duet Sleep Sound Machine 3Health News:Outpatient Disc Treatment Gives Long-Term Back Pain Relief 2Health News:Outpatient Disc Treatment Gives Long-Term Back Pain Relief 3Health News:New Pixantrone Phase III Data to be Presented at the 51st Annual Meeting of the American Society of Hematology 2Health News:New Pixantrone Phase III Data to be Presented at the 51st Annual Meeting of the American Society of Hematology 3Health News:New Pixantrone Phase III Data to be Presented at the 51st Annual Meeting of the American Society of Hematology 4
Alexander periosteal elevators....
Lambotte periosteal elevators....
Cottle periosteal & skin elevator, 7 1/2", slightly curved blade, 9 mm wide....
Dolwick-Reich Condyle periosteal elevator, 17.5 cm, 7"....
Medicine Products: